BillionToOne, Inc. (BLLN) vs CareDx, Inc. (CDNA)
- BillionToOne, Inc. BLLN 98.06 −4.55%
- CareDx, Inc. CDNA 63.81 −4.30%
BillionToOne, Inc. and CareDx, Inc. are both Diagnostics & Research companies. BillionToOne, Inc. is the larger, with a market value of $4.9B against $3.5B — 1.4× the size. CareDx, Inc. trades at the lower P/E: 29.7× against 95.0×. CareDx, Inc. has the higher net margin (24.2% vs 8.35%) and the higher return on invested capital (130.1% vs 34.1%). Across the 19 metrics below, CareDx, Inc. leads on 15 and BillionToOne, Inc. on 4.
Valuation
Profitability
| Metric | BLLN | CDNA | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 71.27% | 70.58% | 50.89% |
| Operating margin | 10.90% | 23.61% | (8.57%) |
| Net margin | 8.35% | 24.23% | (6.37%) |
| Free cash flow margin | 8.35% | 18.49% | 0.00% |
| Return on equity | 23.27% | 29.49% | (2.92%) |
| Return on assets | 9.09% | 22.72% | (6.71%) |
| Return on invested capital | 34.10% | 130.06% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack